Syncom Formulations (India) Limited
SYNCOMF
Rank in Stocks
#16628
Established in 1985 and based in Indore, India, Syncom Formulations (India)... Established in 1985 and based in Indore, India, Syncom Formulations (India) Limited specializes in the development, marketing, and sale of a wide array of finished pharmaceutical products. The company provides an extensive portfolio addressing numerous therapeutic categories, including but not limited to pain relief, infectious diseases, cardiovascular health, mental well-being, respiratory ailments, and nutritional deficiencies, alongside specific treatments for conditions like gout and erectile dysfunction, encompassing both generic and specialized medicines. These medicinal preparations are available in various formats such as tablets, capsules, oral liquids, injectables (both liquid and dry vial), dry syrups, topical ointments, inhalers, and herbal formulations. In addition to its core pharmaceutical business, Syncom Formulations also engages in commodity trading and property leasing. The company serves the domestic Indian market and actively exports its products globally.
Share Price
$0.2139503
Last synced: 2026-11-09
Market Cap
$201.11M
Change (1 day)
0.05%
Change (1 year)
18.30%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Syncom Formulations (India) Limited (SYNCOMF)
Category
Healthcare
Operating Margin for Syncom Formulations (India) Limited (SYNCOMF)
Operating Margin as of November 2026 TTM: 16.29%
According to Syncom Formulations (India) Limited's latest financial reports, its current operating margin (TTM) is 16.29%. At the end of 2025 the company had an operating margin of 10.52%.
Operating Margin history for Syncom Formulations (India) Limited from 2006 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | 16.29% | 54.85% |
| 2025 | 10.52% | 29.56% |
| 2024 | 8.12% | 19.59% |
| 2023 | 6.79% | 0.30% |
| 2022 | 6.77% | -43.58% |
| 2021 | 12.00% | 89.57% |
| 2020 | 6.33% | 46.87% |
| 2019 | 4.31% | -16.80% |
| 2018 | 5.18% | -30.00% |
| 2017 | 7.40% | -10.19% |
| 2016 | 8.24% | -5.61% |
| 2015 | 8.73% | -2.02% |
| 2014 | 8.91% | 21.22% |
| 2013 | 7.35% | 48.19% |
| 2012 | 4.96% | 300.00% |
| 2011 | 1.24% | -85.66% |
| 2010 | 8.65% | -18.09% |
| 2009 | 10.56% | 19.05% |
| 2008 | 8.87% | -26.82% |
| 2007 | 12.12% | 72.40% |
| 2006 | 7.03% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -98.81% |
DE
|
|
| 19.68% | -98.79% |
DE
|
|
| 13.26% | -99.19% |
JP
|
|
| 17.08% | -98.95% |
CH
|
|
| 14.92% | -99.08% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Syncom Formulations (India) Limited's operating margin
What is Syncom Formulations (India) Limited's operating margin?
Syncom Formulations (India) Limited's operating margin is 16.29%, as of Nov 2026.
What was Syncom Formulations (India) Limited's operating margin in 2025?
In 2025, Syncom Formulations (India) Limited's operating margin was 10.52%, compared with 8.12% in 2024.
How has Syncom Formulations (India) Limited's operating margin changed since 2020?
From 2020 to 2025, Syncom Formulations (India) Limited's operating margin was highest in 2021 (12.00%) and lowest in 2020 (6.33%).
How does Syncom Formulations (India) Limited's operating margin compare with similar companies?
Syncom Formulations (India) Limited's operating margin (16.29%) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.